简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-10-25 18:27 DentalMonitoring Now Offers Smart STL* Powered by AI-driven Technology
2022-10-25 15:32 Neuraptive Therapeutics Announces Key Organizational Updates to Support the Company’s Advancements in Nerve Repair
2022-10-25 13:36 Urethral Stricture: BEES-HAUS Cell Therapy Approach Proven With Cell Engraftment by Urologists of Edogawa Hospital, Japan, Holds Potential to Prevent Recurrence.
2022-10-25 12:43 Novaliq Announces FDA Acceptance of the New Drug Application for CyclASol® for the Treatment of Dry Eye Disease
2022-10-25 09:41 USound Reveals High-performing ASIC Linear Audio Amplifier to Boost the Battery Life of TWS, Hearing Aids, and Smart Glasses
2022-10-24 17:00 GQC Is Born: the First Start-up, Federated by PQE Group, to Support Medical Cannabis
2022-10-24 11:21 LEO Pharma Announces European Commission Approval of Adtralza® (tralokinumab) for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents
2022-10-24 09:29 Ferring Presents New Subgroup Analyses of Health-Related Quality of Life and Safety and Efficacy Data at IDWeek 2022 for RBX2660, Its Investigational Microbiota-based Live Biotherapeutic
2022-10-21 21:42 JJP Biologics: The European Commission Has Designated JJP-1212 as an Orphan Medicinal Product.
2022-10-21 09:20 Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy
2022-10-20 16:36 University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs
2022-10-20 13:38 Approval of extension of exemptions from SIX disclosure and publicity obligations
2022-10-18 16:26 Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
2022-10-18 13:29 Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40 Antibody (YH002) and Multiple Active Ingredients to Syncromune for the Development and Commercialization of Intratumoral Immunotherapy
2022-10-18 13:25 ESAB Corporation Acquires Ohio Medical
2022-10-17 19:30 Cancer to Be Treated as Easily as Common Cold When Humans Crack Quantum Computing
2022-10-17 09:04 CHMP recommends conditional marketing authorization for Spesolimab as first in class treatment option for generalized pustular psoriasis flares
2022-10-14 16:14 Wyss Center for Bio and Neuroengineering: New Horizons in Neural Recording Systems
2022-10-14 11:55 Prestige Biopharma Submitted Pre-BLA Type 4 Meeting Request to FDA for Herceptin Biosimilar
2022-10-14 09:31 GE Healthcare Announces Multi-Year Agreement with SQM to Secure Iodine Supply for Contrast Media

Business Wire Weibo

Press Releases

Latest Releases